Skip to main content

Table 3 Adjusted OR for all the other variables

From: Vision loss in patients with giant cell arteritis treated with tocilizumab

Permanent vision loss at baseline Crude OR (95%-CI) p-value Adjusted OR (95%-CI) p-value
  Age at diagnosis 1.07 (1.01 to 1.14) 0.018 1.07 (1.01 to 1.14) 0.021
  CRP (mg/L) 0.98 (0.97 to 1.00) 0.015 0.99 (0.97 to 1.00) 0.040
  Jaw claudication 3.04 (1.20 to 7.70) 0.019 2.34 (0.85 to 6.43) 0.099
  Abnormal MRA aorta 0.27 (0.10 to 0.69) 0.006 0.32 (0.12 to 0.89) 0.028